Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Maggie Starbard/NPR
Rob Stein
Maggie Starbard/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

[+] read more[-] less

Story Archive

A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. Spark Therapeutics hide caption

toggle caption
Spark Therapeutics

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

  • Download
  • <iframe src="https://www.npr.org/player/embed/557183740/557444730" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

3 Americans Win Nobel In Medicine For Circadian Rhythm Research

  • Download
  • <iframe src="https://www.npr.org/player/embed/555170222/555170223" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Vegas Shooting Dominates News; 3 Americans Win Nobel In Medicine

  • Download
  • <iframe src="https://www.npr.org/player/embed/555018505/555035675" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Nobel Prize In Medicine Is Awarded To 3 Americans

  • Download
  • <iframe src="https://www.npr.org/player/embed/554994453/554994454" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Piper Su, seen here with her son, Elliot, lives in Alexandria, Va. She has registered with several transplant centers in hopes of increasing the odds of getting an organ. Courtesy of Piper Su hide caption

toggle caption
Courtesy of Piper Su

Searching For A Fairer Way To Distribute Donor Livers

  • Download
  • <iframe src="https://www.npr.org/player/embed/549224583/553662037" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Kathy Niakan, a developmental biologist at the Francis Crick Institute in London, used the CRISPR gene editing technique to find out how a gene affects the growth of human embryos. Courtesy of The Francis Crick Institute hide caption

toggle caption
Courtesy of The Francis Crick Institute

Editing Embryo DNA Yields Clues About Early Human Development

  • Download
  • <iframe src="https://www.npr.org/player/embed/551779921/552418326" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists have created a treatment in which genetically modified T cells, shown in blue, can attack cancer cells, shown in red. Steve Gschmeissner/Science Source hide caption

toggle caption
Steve Gschmeissner/Science Source

FDA Approves First Gene Therapy For Leukemia

  • Download
  • <iframe src="https://www.npr.org/player/embed/547293551/547373424" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

This sequence of images shows the development of embryos formed after eggs were injected with both CRISPR, a gene-editing tool, and sperm from a donor with a genetic mutation known to cause cardiomyopathy. OHSU hide caption

toggle caption
OHSU

Exclusive: Inside The Lab Where Scientists Are Editing DNA In Human Embryos

  • Download
  • <iframe src="https://www.npr.org/player/embed/543769759/544365096" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The first sign of successful in vitro fertilization, after co-injection of a gene-correcting enzyme and sperm from a donor with a genetic mutation known to cause hypertrophic cardiomyopathy. Courtesy of OHSU hide caption

toggle caption
Courtesy of OHSU

Scientists Precisely Edit DNA In Human Embryos To Fix A Disease Gene

  • Download
  • <iframe src="https://www.npr.org/player/embed/540975224/541197557" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An international team of scientists analyzed data from men around the world and found sperm counts declining in Western countries. Hanna Barczyk for NPR hide caption

toggle caption
Hanna Barczyk for NPR

Sperm Counts Plummet In Western Men, Study Finds

  • Download
  • <iframe src="https://www.npr.org/player/embed/539517210/540515388" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

FDA Announces Plan To Cut Level Of Nicotine Allowed In Cigarettes

  • Download
  • <iframe src="https://www.npr.org/player/embed/540088353/540088355" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

FDA Announces Plan To Cut Level Of Nicotine Allowed In Cigarettes

  • Download
  • <iframe src="https://www.npr.org/player/embed/540088353/540088355" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript